Vir Biotechnology | 8-K: Vir Biotechnology Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Vir Biotechnology | 8-K: Current report
Vir Biotechnology | 8-K: Vir Biotechnology Reports Second Quarter 2024 Financial Results and Announces Strategic Restructuring to Prioritize Clinical-Stage Pipeline Opportunities
Vir Biotechnology | 8-K: Current report
Vir Biotechnology | 8-K: Current report
Vir Biotechnology | 8-K: Current report
Vir Biotechnology | 8-K: Current report
Vir Biotechnology | DEFA14A: Others
Vir Biotechnology | 8-K: Vir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial Results
Vir Biotechnology | DEFA14A: Others
Vir Biotechnology | DEF 14A: Definitive information statements
Vir Biotechnology | 8-K: Current report
Vir Biotechnology | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Vir Biotechnology | 8-K: Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
Vir Biotechnology | 8-K: Current report
Vir Biotechnology | 8-K: Current report
Vir Biotechnology | 8-K: Current report
Vir Biotechnology | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Vir Biotechnology | 8-K: Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2023 Financial Results
Vir Biotechnology | 8-K: Current report
No Data
No Data